Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y8IE
|
|||
| Former ID |
DIB010055
|
|||
| Drug Name |
AR-13165
|
|||
| Synonyms |
AR-13165 series; Dual-targeting compounds (Glaucoma); Dual-targeting compounds (Glaucoma), Aerie
Click to Show/Hide
|
|||
| Indication | Glaucoma/ocular hypertension [ICD-11: 9C61; ICD-9: 365] | Phase 3 | [1] | |
| Company |
Aerie Pharmaceuticals Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02207621) A Double-masked Study of AR-13324 in Patients With Glaucoma and Ocular Hypertension. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.